Does the presence of interatrial block predict new-onset atrial fibrillation, transient ischemic attack, or ischemic stroke in patients with hypertrophic cardiomyopathy?
Interatrial block (P-wave >120 ms) is a simple, accessible ECG marker that identifies hypertrophic cardiomyopathy patients with advanced left atrial remodeling and a higher risk of incident atrial fibrillation and stroke.
BACKGROUND: Interatrial block (IAB) has been associated with atrial fibrillation (AF) and stroke in broader cardiovascular populations. Whether these associations extend to hypertrophic cardiomyopathy (HCM) and how IAB relates to underlying left atrial (LA) remodeling remain unknown. OBJECTIVE: This study aimed to investigate the prevalence, morphofunctional correlates, and prognostic value of IAB in patients with HCM. METHODS: This multicenter study included 259 patients with HCM without a history of AF/stroke. IAB was defined by a P-wave duration of >120 ms. Associations between morphologic and functional parameters of the LA and IAB were assessed using cardiac magnetic resonance imaging. The primary composite endpoint was new-onset AF, transient ischemic attack, or ischemic stroke. RESULTS: IAB was present in 10% of the cohort. Patients with IAB exhibited larger LA diameter (median 47.4 vs 43.2 mm; P = .022), larger indexed maximum LA volume (median 52.5 vs 46.9 mL/m CONCLUSION: In patients with HCM, IAB is associated with significant LA structural and functional impairments, indicative of advanced atrial cardiomyopathy. Its presence was independently associated with an increased risk of incident AF and stroke, suggesting its value as a simple, accessible electrocardiographic marker for enhanced risk stratification.
Musa et al. (Sun,) studied this question.